The ability to detect diseases at an early stage or even predict their onset would be of tremendous benefit to doctors and patients alike. A research team led by Dr. Larysa Baraban at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) develops intelligent, miniaturized biosensor devices and systems using nanomaterials to determine biomolecules and cells as well as biochemical reactions or processes as disease markers.
